APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Follicle Stimulating Hormone

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Recombinant Follicle Stimulating Hormone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025184 pages

Choose your research edition.

Industry ResearchRecombinant Follicle Stimulating Hormone Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Follicle Stimulating Hormone Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Recombinant Follicle Stimulating Hormone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Follicle Stimulating Hormone Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Follicle Stimulating Hormone Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Recombinant Follicle Stimulating Hormone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Recombinant Follicle Stimulating Hormone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Recombinant Follicle Stimulating Hormone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Follicle Stimulating Hormone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Recombinant Follicle Stimulating Hormone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Follicle Stimulating Hormone include Teva, MSD, Merck Serono, Techwell, GenSci and Gedeon Richter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Recombinant Follicle Stimulating Hormone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Recombinant Follicle Stimulating Hormone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Recombinant Follicle Stimulating Hormone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Recombinant Follicle Stimulating Hormone market size, projected growth trends, production technologies, key applications, and end-use industries.

Recombinant Follicle Stimulating Hormone Segment by Company

Teva

MSD

Merck Serono

Techwell

GenSci

Gedeon Richter

Recombinant Follicle Stimulating Hormone Segment by Type

75IU

150IU

Others

Recombinant Follicle Stimulating Hormone Segment by Application

Infertility Treatment

Assisted Reproductive Technology

Recombinant Follicle Stimulating Hormone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Follicle Stimulating Hormone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Follicle Stimulating Hormone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Follicle Stimulating Hormone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Recombinant Follicle Stimulating Hormone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Follicle Stimulating Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Recombinant Follicle Stimulating Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Recombinant Follicle Stimulating Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Recombinant Follicle Stimulating Hormone Industry Trends Table 2. Recombinant Follicle Stimulating Hormone Industry Drivers Table 3. Recombinant Follicle Stimulating Hormone Industry Opportunities and Challenges Table 4. Recombinant Follicle Stimulating Hormone Industry Restraints Table 5. Global Recombinant Follicle Stimulating Hormone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Recombinant Follicle Stimulating Hormone Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Manufacturers Table 9. Global Recombinant Follicle Stimulating Hormone Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Recombinant Follicle Stimulating Hormone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Recombinant Follicle Stimulating Hormone Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Recombinant Follicle Stimulating Hormone Manufacturers, Product Type & Application Table 13. Global Recombinant Follicle Stimulating Hormone Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Recombinant Follicle Stimulating Hormone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 75IU Table 17. Major Manufacturers of 150IU Table 18. Major Manufacturers of Others Table 19. Global Recombinant Follicle Stimulating Hormone Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Recombinant Follicle Stimulating Hormone Sales by Type (2021-2026) & (K Units) Table 21. Global Recombinant Follicle Stimulating Hormone Sales by Type (2027-2032) & (K Units) Table 22. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2021-2026) Table 23. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2027-2032) Table 24. Global Recombinant Follicle Stimulating Hormone Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Recombinant Follicle Stimulating Hormone Revenue by Type (2021-2026) & (K Units) Table 26. Global Recombinant Follicle Stimulating Hormone Revenue by Type (2027-2032) & (K Units) Table 27. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Type (2021-2026) Table 28. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Infertility Treatment Table 30. Major Manufacturers of Assisted Reproductive Technology Table 31. Global Recombinant Follicle Stimulating Hormone Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Recombinant Follicle Stimulating Hormone Sales by Application (2021-2026) & (K Units) Table 33. Global Recombinant Follicle Stimulating Hormone Sales by Application (2027-2032) & (K Units) Table 34. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2021-2026) Table 35. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2027-2032) Table 36. Global Recombinant Follicle Stimulating Hormone Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Recombinant Follicle Stimulating Hormone Revenue by Application (2021-2026) & (K Units) Table 38. Global Recombinant Follicle Stimulating Hormone Revenue by Application (2027-2032) & (K Units) Table 39. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Application (2021-2026) Table 40. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Application (2027-2032) Table 41. Global Recombinant Follicle Stimulating Hormone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Recombinant Follicle Stimulating Hormone Sales by Region (2021-2026) & (K Units) Table 43. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Region (2021-2026) Table 44. Global Recombinant Follicle Stimulating Hormone Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Recombinant Follicle Stimulating Hormone Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Recombinant Follicle Stimulating Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Recombinant Follicle Stimulating Hormone Sales by Country (2021-2026) & (K Units) Table 48. North America Recombinant Follicle Stimulating Hormone Sales by Country (2027-2032) & (K Units) Table 49. Europe Recombinant Follicle Stimulating Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2021-2026) & (K Units) Table 51. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Recombinant Follicle Stimulating Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Recombinant Follicle Stimulating Hormone Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Recombinant Follicle Stimulating Hormone Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2027-2032) & (K Units) Table 58. Global Recombinant Follicle Stimulating Hormone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Recombinant Follicle Stimulating Hormone Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Recombinant Follicle Stimulating Hormone Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Region (2021-2026) Table 62. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Region (2027-2032) Table 63. Teva Company Information Table 64. Teva Business Overview Table 65. Teva Recombinant Follicle Stimulating Hormone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Teva Recombinant Follicle Stimulating Hormone Product Portfolio Table 67. Teva Recent Development Table 68. MSD Company Information Table 69. MSD Business Overview Table 70. MSD Recombinant Follicle Stimulating Hormone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. MSD Recombinant Follicle Stimulating Hormone Product Portfolio Table 72. MSD Recent Development Table 73. Merck Serono Company Information Table 74. Merck Serono Business Overview Table 75. Merck Serono Recombinant Follicle Stimulating Hormone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck Serono Recombinant Follicle Stimulating Hormone Product Portfolio Table 77. Merck Serono Recent Development Table 78. Techwell Company Information Table 79. Techwell Business Overview Table 80. Techwell Recombinant Follicle Stimulating Hormone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Techwell Recombinant Follicle Stimulating Hormone Product Portfolio Table 82. Techwell Recent Development Table 83. GenSci Company Information Table 84. GenSci Business Overview Table 85. GenSci Recombinant Follicle Stimulating Hormone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. GenSci Recombinant Follicle Stimulating Hormone Product Portfolio Table 87. GenSci Recent Development Table 88. Gedeon Richter Company Information Table 89. Gedeon Richter Business Overview Table 90. Gedeon Richter Recombinant Follicle Stimulating Hormone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Gedeon Richter Recombinant Follicle Stimulating Hormone Product Portfolio Table 92. Gedeon Richter Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Recombinant Follicle Stimulating Hormone Distributors List Table 96. Recombinant Follicle Stimulating Hormone Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Recombinant Follicle Stimulating Hormone Product Image Figure 2. Global Recombinant Follicle Stimulating Hormone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Follicle Stimulating Hormone Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Follicle Stimulating Hormone Sales (2021-2032) & (K Units) Figure 5. Global Recombinant Follicle Stimulating Hormone Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Recombinant Follicle Stimulating Hormone Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 75IU Image Figure 9. 150IU Image Figure 10. Others Image Figure 11. Global Recombinant Follicle Stimulating Hormone Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Recombinant Follicle Stimulating Hormone Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2021-2032) Figure 14. Global Recombinant Follicle Stimulating Hormone Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Recombinant Follicle Stimulating Hormone Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Type (2021-2032) Figure 17. Infertility Treatment Image Figure 18. Assisted Reproductive Technology Image Figure 19. Global Recombinant Follicle Stimulating Hormone Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Recombinant Follicle Stimulating Hormone Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2021-2032) Figure 22. Global Recombinant Follicle Stimulating Hormone Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Recombinant Follicle Stimulating Hormone Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Application (2021-2032) Figure 25. North America Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2021-2032) Figure 27. U.S. Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2021-2032) Figure 32. Germany Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2021-2032) Figure 39. China Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2021-2032) Figure 47. Brazil Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Recombinant Follicle Stimulating Hormone Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Recombinant Follicle Stimulating Hormone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Recombinant Follicle Stimulating Hormone Revenue (2021-2032) & (US$ Million) Figure 58. North America Recombinant Follicle Stimulating Hormone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Recombinant Follicle Stimulating Hormone Revenue (2021-2032) & (US$ Million) Figure 60. Europe Recombinant Follicle Stimulating Hormone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Recombinant Follicle Stimulating Hormone Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Recombinant Follicle Stimulating Hormone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Recombinant Follicle Stimulating Hormone Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Recombinant Follicle Stimulating Hormone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Recombinant Follicle Stimulating Hormone Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Recombinant Follicle Stimulating Hormone Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 75IU
  • 150IU
  • Others
Applications
  • Infertility Treatment
  • Assisted Reproductive Technology
Companies covered
  • Teva
  • MSD
  • Merck Serono
  • Techwell
  • GenSci
  • Gedeon Richter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Recombinant Follicle Stimulating Hormone Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Recombinant Follicle Stimulating Hormone Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Recombinant Follicle Stimulating Hormone Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Recombinant Follicle Stimulating Hormone Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Recombinant Follicle Stimulating Hormone Market Dynamics
  1. 2.1 Recombinant Follicle Stimulating Hormone Industry Trends
  2. 2.2 Recombinant Follicle Stimulating Hormone Industry Drivers
  3. 2.3 Recombinant Follicle Stimulating Hormone Industry Opportunities and Challenges
  4. 2.4 Recombinant Follicle Stimulating Hormone Industry Restraints
3 Recombinant Follicle Stimulating Hormone Market by Manufacturers
  1. 3.1 Global Recombinant Follicle Stimulating Hormone Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Recombinant Follicle Stimulating Hormone Sales by Manufacturers (2021-2026)
  3. 3.3 Global Recombinant Follicle Stimulating Hormone Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Recombinant Follicle Stimulating Hormone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Follicle Stimulating Hormone Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Recombinant Follicle Stimulating Hormone Manufacturers, Product Type & Application
  7. 3.7 Global Recombinant Follicle Stimulating Hormone Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Follicle Stimulating Hormone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Follicle Stimulating Hormone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Follicle Stimulating Hormone Tier 1, Tier 2, and Tier 3
4 Recombinant Follicle Stimulating Hormone Market by Type
  1. 4.1 Recombinant Follicle Stimulating Hormone Type Introduction
  2. 4.1.1 75IU
  3. 4.1.2 150IU
  4. 4.1.3 Others
  5. 4.2 Global Recombinant Follicle Stimulating Hormone Sales by Type
  6. 4.2.1 Global Recombinant Follicle Stimulating Hormone Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Recombinant Follicle Stimulating Hormone Sales by Type (2021-2032)
  8. 4.2.3 Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2021-2032)
  9. 4.3 Global Recombinant Follicle Stimulating Hormone Revenue by Type
  10. 4.3.1 Global Recombinant Follicle Stimulating Hormone Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Recombinant Follicle Stimulating Hormone Revenue by Type (2021-2032)
  12. 4.3.3 Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Type (2021-2032)
5 Recombinant Follicle Stimulating Hormone Market by Application
  1. 5.1 Recombinant Follicle Stimulating Hormone Application Introduction
  2. 5.1.1 Infertility Treatment
  3. 5.1.2 Assisted Reproductive Technology
  4. 5.2 Global Recombinant Follicle Stimulating Hormone Sales by Application
  5. 5.2.1 Global Recombinant Follicle Stimulating Hormone Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Recombinant Follicle Stimulating Hormone Sales by Application (2021-2032)
  7. 5.2.3 Global Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2021-2032)
  8. 5.3 Global Recombinant Follicle Stimulating Hormone Revenue by Application
  9. 5.3.1 Global Recombinant Follicle Stimulating Hormone Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Recombinant Follicle Stimulating Hormone Revenue by Application (2021-2032)
  11. 5.3.3 Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Application (2021-2032)
6 Global Recombinant Follicle Stimulating Hormone Sales by Region
  1. 6.1 Global Recombinant Follicle Stimulating Hormone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Recombinant Follicle Stimulating Hormone Sales by Region (2021-2032)
  3. 6.2.1 Global Recombinant Follicle Stimulating Hormone Sales by Region (2021-2026)
  4. 6.2.2 Global Recombinant Follicle Stimulating Hormone Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Recombinant Follicle Stimulating Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Recombinant Follicle Stimulating Hormone Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Recombinant Follicle Stimulating Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Recombinant Follicle Stimulating Hormone Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Recombinant Follicle Stimulating Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Recombinant Follicle Stimulating Hormone Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Recombinant Follicle Stimulating Hormone Revenue by Region
  1. 7.1 Global Recombinant Follicle Stimulating Hormone Revenue by Region
  2. 7.1.1 Global Recombinant Follicle Stimulating Hormone Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Recombinant Follicle Stimulating Hormone Revenue by Region (2021-2026)
  4. 7.1.3 Global Recombinant Follicle Stimulating Hormone Revenue by Region (2027-2032)
  5. 7.1.4 Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Recombinant Follicle Stimulating Hormone Revenue (2021-2032)
  8. 7.2.2 North America Recombinant Follicle Stimulating Hormone Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Recombinant Follicle Stimulating Hormone Revenue (2021-2032)
  11. 7.3.2 Europe Recombinant Follicle Stimulating Hormone Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Recombinant Follicle Stimulating Hormone Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Recombinant Follicle Stimulating Hormone Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Recombinant Follicle Stimulating Hormone Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Recombinant Follicle Stimulating Hormone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Recombinant Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Recombinant Follicle Stimulating Hormone Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 MSD
  8. 8.2.1 MSD Company Information
  9. 8.2.2 MSD Business Overview
  10. 8.2.3 MSD Recombinant Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 MSD Recombinant Follicle Stimulating Hormone Product Portfolio
  12. 8.2.5 MSD Recent Developments
  13. 8.3 Merck Serono
  14. 8.3.1 Merck Serono Company Information
  15. 8.3.2 Merck Serono Business Overview
  16. 8.3.3 Merck Serono Recombinant Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Serono Recombinant Follicle Stimulating Hormone Product Portfolio
  18. 8.3.5 Merck Serono Recent Developments
  19. 8.4 Techwell
  20. 8.4.1 Techwell Company Information
  21. 8.4.2 Techwell Business Overview
  22. 8.4.3 Techwell Recombinant Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Techwell Recombinant Follicle Stimulating Hormone Product Portfolio
  24. 8.4.5 Techwell Recent Developments
  25. 8.5 GenSci
  26. 8.5.1 GenSci Company Information
  27. 8.5.2 GenSci Business Overview
  28. 8.5.3 GenSci Recombinant Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GenSci Recombinant Follicle Stimulating Hormone Product Portfolio
  30. 8.5.5 GenSci Recent Developments
  31. 8.6 Gedeon Richter
  32. 8.6.1 Gedeon Richter Company Information
  33. 8.6.2 Gedeon Richter Business Overview
  34. 8.6.3 Gedeon Richter Recombinant Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Gedeon Richter Recombinant Follicle Stimulating Hormone Product Portfolio
  36. 8.6.5 Gedeon Richter Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Recombinant Follicle Stimulating Hormone Value Chain Analysis
  2. 9.1.1 Recombinant Follicle Stimulating Hormone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Recombinant Follicle Stimulating Hormone Production Mode & Process
  6. 9.2 Recombinant Follicle Stimulating Hormone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Recombinant Follicle Stimulating Hormone Distributors
  9. 9.2.3 Recombinant Follicle Stimulating Hormone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst